111 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 32391926 | Sorafenib induces pigmentation via the regulation of β-catenin signalling pathway in melanoma cells. | 2022 Jan | 1 |
2 | 34764205 | The Protein Kinase Activity of NME7 Activates Wnt/β-Catenin Signaling to Promote One-Carbon Metabolism in Hepatocellular Carcinoma. | 2022 Jan 1 | 1 |
3 | 35090098 | Protein phosphatase 1 regulatory inhibitor subunit 14C promotes triple-negative breast cancer progression via sustaining inactive glycogen synthase kinase 3 beta. | 2022 Jan | 1 |
4 | 35347072 | eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma. | 2022 Mar | 1 |
5 | 35390715 | Development of inhibitors targeting glycogen synthase kinase-3β for human diseases: Strategies to improve selectivity. | 2022 Jun 5 | 1 |
6 | 35402914 | Malignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41, GSK-3β inhibitor, monotherapy or combined with chemotherapy for refractory malignancies. | 2022 Jan-Dec | 1 |
7 | 35409221 | Identification of Novel GSK-3β Hits Using Competitive Biophysical Assays. | 2022 Mar 31 | 1 |
8 | 35568694 | Mammalian eIF4E2-GSK3β maintains basal phosphorylation of p53 to resist senescence under hypoxia. | 2022 May 14 | 1 |
9 | 35607451 | Melatonin increases growth properties in human dermal papilla spheroids by activating AKT/GSK3β/β-Catenin signaling pathway. | 2022 | 2 |
10 | 33030673 | Tideglusib attenuates growth of neuroblastoma cancer stem/progenitor cells in vitro and in vivo by specifically targeting GSK-3β. | 2021 Feb | 1 |
11 | 33188146 | FBW7 Inhibits Myeloid Differentiation in Acute Myeloid Leukemia via GSK3-Dependent Ubiquitination of PU.1. | 2021 Feb | 1 |
12 | 33309639 | SCRT1 is a novel beta cell transcription factor with insulin regulatory properties. | 2021 Feb 5 | 1 |
13 | 33327806 | Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and in silico studies. | 2021 Dec | 1 |
14 | 33414248 | Placental Insulin/IGF-1 Signaling, PGC-1α, and Inflammatory Pathways Are Associated With Metabolic Outcomes at 4-6 Years of Age: The ECHO Healthy Start Cohort. | 2021 Mar | 1 |
15 | 33461462 | Anti-inflammatory Potential of GSK-3 Inhibitors. | 2021 | 5 |
16 | 33492962 | Novel 18F-Labeled Isonicotinamide-Based Radioligands for Positron Emission Tomography Imaging of Glycogen Synthase Kinase-3β. | 2021 Mar 1 | 1 |
17 | 33682722 | Dysregulation of GSK3β-Target Proteins in Skin Fibroblasts of Myotonic Dystrophy Type 1 (DM1) Patients. | 2021 | 1 |
18 | 33918222 | Additional Inhibition of Wnt/β-Catenin Signaling by Metformin in DAA Treatments as a Novel Therapeutic Strategy for HCV-Infected Patients. | 2021 Apr 2 | 1 |
19 | 33951093 | GSK3ß inhibitor CHIR 99021 modulates cerebral organoid development through dose-dependent regulation of apoptosis, proliferation, differentiation and migration. | 2021 | 1 |
20 | 34002210 | ANXA1-GSK3β interaction and its involvement in NSCLC metastasis. | 2021 Jul 5 | 1 |
21 | 34023818 | Glycogen synthase kinase-3 beta (GSK3β)-mediated phosphorylation of ETS1 promotes progression of ovarian carcinoma. | 2021 May 23 | 1 |
22 | 34162041 | AGEs promote calcification of HASMCs by mediating Pi3k/AKT-GSK3β signaling. | 2021 May 30 | 1 |
23 | 34198826 | Glycogen Synthase Kinase 3 Beta Regulates the Human Aryl Hydrocarbon Receptor Cellular Content and Activity. | 2021 Jun 5 | 1 |
24 | 34206370 | Repurposing Niclosamide for Targeting Pancreatic Cancer by Inhibiting Hh/Gli Non-Canonical Axis of Gsk3β. | 2021 Jun 22 | 1 |
25 | 34406791 | Keratin 19 interacts with GSK3β to regulate its nuclear accumulation and degradation of cyclin D3. | 2021 Nov 1 | 1 |
26 | 34461526 | GSK3β as a novel promising target to overcome chemoresistance in pancreatic cancer. | 2021 Sep | 1 |
27 | 34569452 | Screening of Azadirachta indica phytoconstituents as GSK-3β inhibitor and its implication in neuroblastoma: molecular docking, molecular dynamics, MM-PBSA binding energy, and in-vitro study. | 2021 Sep 27 | 1 |
28 | 34589270 | TAM-derived extracellular vesicles containing microRNA-29a-3p explain the deterioration of ovarian cancer. | 2021 Sep 3 | 2 |
29 | 34732689 | GSK-3β manipulates ferroptosis sensitivity by dominating iron homeostasis. | 2021 Nov 3 | 1 |
30 | 34948382 | GSK3β Serine 389 Phosphorylation Modulates Cardiomyocyte Hypertrophy and Ischemic Injury. | 2021 Dec 18 | 4 |
31 | 34975828 | GSK3β Interacts With CRMP2 and Notch1 and Controls T-Cell Motility. | 2021 | 1 |
32 | 31785335 | Emerging roles of GSK-3α in pathophysiology: Emphasis on cardio-metabolic disorders. | 2020 Feb | 1 |
33 | 31919413 | GSK3β is a key regulator of the ROS-dependent necrotic death induced by the quinone DMNQ. | 2020 Jan 2 | 1 |
34 | 32307979 | Effects of Arsenic on wnt/β-catenin Signaling Pathway: A Systematic Review and Meta-analysis. | 2020 Jun 15 | 1 |
35 | 32344182 | Genetic mutational analysis of β-catenin gene affecting GSK-3β phosphorylation plays a role in gallbladder carcinogenesis: Results from a case control study. | 2020 Apr 21 | 1 |
36 | 32395524 | Dezocine regulates the malignant potential and aerobic glycolysis of liver cancer targeting Akt1/GSK-3β pathway. | 2020 Apr | 1 |
37 | 32425837 | Novel Treatment Strategies Targeting Myelin and Oligodendrocyte Dysfunction in Schizophrenia. | 2020 | 1 |
38 | 32470749 | The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor. | 2020 Aug | 14 |
39 | 32481626 | Hypoxia-Induced miR-675-5p Supports β-Catenin Nuclear Localization by Regulating GSK3-β Activity in Colorectal Cancer Cell Lines. | 2020 May 28 | 1 |
40 | 32503133 | Glycogen Synthase Kinase 3β in Cancer Biology and Treatment. | 2020 Jun 3 | 3 |
41 | 32521784 | Glycogen Synthase Kinase-3β Facilitates Cytokine Production in 12-O-Tetradecanoylphorbol-13-Acetate/Ionomycin-Activated Human CD4+ T Lymphocytes. | 2020 Jun 8 | 1 |
42 | 32850361 | The Role of GSK3β in T Lymphocytes in the Tumor Microenvironment. | 2020 | 1 |
43 | 32855684 | CD147 promotes epithelial-mesenchymal transition of prostate cancer cells via the Wnt/β-catenin pathway. | 2020 Oct | 1 |
44 | 33052244 | Glycogen synthase kinase-3β: a promising candidate in the fight against fibrosis. | 2020 | 2 |
45 | 33080467 | The role of glycogen synthase kinase 3 beta in multiple sclerosis. | 2020 Dec | 1 |
46 | 33110983 | Machine Learning for Discovery of GSK3β Inhibitors. | 2020 Oct 20 | 2 |
47 | 33125126 | Glycogen synthase kinase 3β in tumorigenesis and oncotherapy (Review). | 2020 Dec | 1 |
48 | 33343576 | Inhibition of Glycogen Synthase Kinase 3β Increases the Proportion and Suppressive Function of CD19+CD24hiCD27+ Breg Cells. | 2020 | 1 |
49 | 33362958 | Dysregulated levels of glycogen synthase kinase-3β (GSK-3β) and miR-135 in peripheral blood samples of cases with nephrotic syndrome. | 2020 | 1 |
50 | 29631413 | Nanotized PPARα Overexpression Targeted to Hypertrophied Myocardium Improves Cardiac Function by Attenuating the p53-GSK3β-Mediated Mitochondrial Death Pathway. | 2019 Feb 10 | 4 |